MK-2866 33mg per ml 30ml

MK-2866, is considered to be a part of the selective androgen receptor modulator class of drugs. Selective androgen receptor modulators (SARMs) differentially bind to androgen receptors depending on each SARM’s chemical structure. As a result, SARMs result in anabolic cellular activity while avoiding many of the side effects of currently available anabolic steroids. SARMs have been studied in the treatment of breast cancer and cachexia and have also been used as performance enhancing agents.The result is that MK-2866 Ostarine shows the ability to strengthen muscles, increase bone density, and stimulate faster recovery in rats.